|Day Low/High||79.62 / 83.19|
|52 Wk Low/High||35.83 / 120.94|
Cramer says sell Stryker and buy Zimmer Biomet, and take Randgold over Barrick Gold.
The economy needs consumers to buy, buy, buy but so far consumers have been all over the map, Cramer says.
Nasdaq-traded marijuana stocks are undervalued as investors remain skittish and the use of drugs produced by these biopharmaceutical companies have not been widely adopted.
Investors should stick with buying stocks in the utilities and consumer staples sectors, which rose higher in the aftermath of the Brexit vote and avoided the massive volatility.
Shares of GW Pharmaceuticals are on the rise after the company announced this morning positive Phase 3 results for its Epidiolex for the treatment of Lennox-Gastaut syndrome, or LGS.
Trade-Ideas LLC identified GW Pharmaceuticals (GWPH) as a pre-market mover with heavy volume candidate
GW Pharmaceuticals announced positive results Monday from a second, pivotal clinical trial involving children with a severe form of epilepsy treated with its experimental marijuana-based drug.
Folks are anxious, dying to be bullish yet also curbing their enthusiasm.
It may not be the likeliest of scenarios, but if Gary Johnson becomes president of the United States, investors might want to shift some money around. Here's how.
'Brexit' will be Cramer's focus, along with company earnings and Fed Chair Janet Yellen's congressional testimony.
Cramer says American Tower is a buy and is hesitant on B&G Foods.
As more states consider legalizing the drug for recreational use, forward-thinking investors are wondering how to profit.
Cramer says Time Warner is a good stock but you should sell Interoil.
How does Cramer know that investors are getting careless? Because they see takeovers everywhere.
Weed has gone from a taboo substance to a multi-billion-dollar bonanza. The growth of the marijuana sector has created opportunities for investors. Here are four to watch.
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Investors choosing among the hundreds of cannabis businesses are often caught in a conundrum as to whether medical companies are a safer investment compared to recreational businesses.